• Department of Thoracic Surgery, Gansu Province People’s Hospital, Lanzhou, 730000, P. R. China;
GOU Yunjiu, Email: gouyunjiu@163.com
Export PDF Favorites Scan Get Citation

Objective To explore the application of Toumai® minimally invasive endoscopic robot in thoracic surgery, and to observe its safety and short-term surgical efficacy. Methods Three patients were enrolled from October to December 2021, including 1 male (69 years) and 2 females (47 years and 22 years). All 3 patients received surgery with Toumai® endoscopic surgical robot, including radical lung cancer surgery in 2 patients and mediastinal tumor resection in 1 patient. Results All 3 patients were successfully operated without conversion to thoracotomy, complication or death. For the male lobectomy patient, the total operation time was 120 min, the intraoperative blood loss was 100 mL, the catheter drainage time was 4 days and the hospital stay time was 5 days. For the female lobectomy patient, the total operation time was 103 min, the intraoperative blood loss was 100 mL, the catheter drainage time was 4 days and the hospital stay time was 5 days. For the female mediastinal tumor patient, the total operation time was 81 min, the intraoperative blood loss was 50 mL, the catheter drainage time was 3 days and the hospital stay time was 3 days. Conclusion The Toumai® minimally invasive endoscopic surgical robot is safe and effective in thoracic surgery. Compared with Da Vinci surgical robot, Toumai® has the same 3D visual field experience and smooth operation.

Citation: JIN Dacheng, CUI Baiqiang, YANG Ning, HE Xiaoyang, GOU Yunjiu. Toumai® endoscopic robot-assisted thoracic surgery in three patients. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2022, 29(4): 524-528. doi: 10.7507/1007-4848.202112058 Copy

  • Previous Article

    Relation between age and postoperative pathological features of patients with colorectal cancer: a real-world study based on DACCA
  • Next Article

    Diagnostic value of multi-slice spiral CT on metastatic lymph node and N stage of resectable gastric cancer